Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenus
247,707
243,025
236,950
260,908
272,944
223,016
Croissance des revenus (H/H)
3%
3%
-9%
-4%
22%
18%
Coût des ventes
176,670
175,827
173,715
170,984
161,145
146,808
Bénéfice brut
71,037
67,198
63,235
89,924
111,799
76,208
Vente, Général et Administration
66,876
47,781
50,046
51,572
51,184
42,090
Recherche et développement
--
10,894
11,262
9,556
7,281
5,944
Frais d'exploitation
66,877
64,558
67,278
66,543
61,309
50,816
Autres revenus (charges) non opérationnels
-849
-258
-910
-139
-1,778
555
Bénéfice avant impôts
6,981
3,215
-7,619
22,907
41,323
20,823
Charge d'impôt sur le revenu
1,527
483
-66
7,230
11,710
3,398
Bénéfice net
5,571
2,761
-7,553
15,676
29,599
17,468
Croissance du bénéfice net
-494%
-137%
-148%
-47%
69%
-3,485%
Actions en circulation (diluées)
55.59
56.81
56.88
56.9
56.98
57.02
Variation des actions (H-H)
-2%
0%
0%
0%
0%
0%
EPS (dilué)
100.2
48.59
-132.77
275.49
519.41
306.31
Croissance du EPS
-503%
-137%
-148%
-47%
70%
-3,482%
Flux de trésorerie libre
14,956
11,650
-1,007
10,848
20,104
14,513
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
28.67%
27.65%
26.68%
34.46%
40.96%
34.17%
Marge opérationnelle
1.67%
1.08%
-1.7%
8.96%
18.49%
11.38%
Marge bénéficiaire
2.24%
1.13%
-3.18%
6%
10.84%
7.83%
Marge du flux de trésorerie libre
6.03%
4.79%
-0.42%
4.15%
7.36%
6.5%
EBITDA
26,067
23,386
16,827
43,075
65,116
37,886
Marge EBITDA
10.52%
9.62%
7.1%
16.5%
23.85%
16.98%
D&A pour le résultat opérationnel
21,907
20,746
20,870
19,694
14,626
12,494
EBIT
4,160
2,640
-4,043
23,381
50,490
25,392
Marge EBIT
1.67%
1.08%
-1.7%
8.96%
18.49%
11.38%
Taux d'imposition effectif
21.87%
15.02%
0.86%
31.56%
28.33%
16.31%
Statistiques clés
Clôture préc.
$19.88
Prix d'ouverture
$20.99
Plage de la journée
$20.99 - $20.99
Plage de 52 semaines
$14.87 - $28.06
Volume
100
Volume moyen
160
BPA (TTM)
0.31
Rendement en dividend
--
Capitalisation boursière
$1.2B
Qu’est-ce que MRCHF ?
H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,444 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.